Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population

Two-dimensional speckle-tracking echocardiography (2DSTE) detects myocardial dysfunction despite a preserved left ventricular ejection fraction. Fibroblast growth factor 23 (FGF23) has become a promising biomarker of cardiovascular risk. This study aimed to determine whether FGF23 may be used as a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurpas, Anna, Supel, Karolina, Wieczorkiewicz, Paulina, Bodalska Duleba, Joanna, Zielinska, Marzenna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294899/
https://www.ncbi.nlm.nih.gov/pubmed/37371618
http://dx.doi.org/10.3390/biomedicines11061523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294899/
https://www.ncbi.nlm.nih.gov/pubmed/37371618
http://dx.doi.org/10.3390/biomedicines11061523

Ejemplares similares